Diabetogenic effect of statins: a double-edged sword?

scientific article published on December 2013

Diabetogenic effect of statins: a double-edged sword? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4093/DMJ.2013.37.6.415
P932PMC publication ID3881325
P698PubMed publication ID24404512
P5875ResearchGate publication ID259632075

P50authorJi Sung YoonQ81337201
P2093author name stringHyoung Woo Lee
P2860cites workSecondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trialQ44599698
Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndromeQ45180875
Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patientsQ46533533
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysisQ46810855
Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA)Q57281927
Statins and new-onset diabetes—the important questionsQ57606219
Direct Effect of Cholesterol on Insulin Secretion: A Novel Mechanism for Pancreatic -Cell DysfunctionQ60642303
A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemiaQ72577492
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery diseaseQ79368237
Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgiaQ79788074
Are statins diabetogenic?Q24630205
Nitric oxide induces apoptosis via Ca2+-dependent processes in the pancreatic beta-cell line MIN6Q28372031
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive proteinQ29547752
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsQ29622947
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention StudyQ31829404
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialQ33966645
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysisQ34027392
Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trialsQ34142678
Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.Q34245974
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trialQ34293369
Standards of medical care in diabetes--2011.Q34425055
Safety and efficacy of statins in AsiansQ34574500
Rosuvastatin in older patients with systolic heart failureQ34710349
Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cellsQ35028546
Effect of statins on skeletal muscle: exercise, myopathy, and muscle outcomesQ36294928
Risk of incident diabetes among patients treated with statins: population based study.Q36871618
Statin therapy and risk of developing type 2 diabetes: a meta-analysisQ37364976
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysisQ37632786
Differential metabolic effects of distinct statins.Q37815804
Coenzyme q10 and statin-induced mitochondrial dysfunction.Q37878308
Management of cardiovascular risk: the importance of meeting lipid targetsQ38018650
Statins are diabetogenic--myth or reality?Q38028072
Do statins cause diabetes?Q38086101
Statins for primary prevention of cardiovascular disease: the benefits outweigh the risksQ38127588
Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trialsQ39765409
Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cellsQ39965445
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic controlQ42802278
Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteinsQ42814670
Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytesQ42823990
Effect of pravastatin on the development of diabetes and adiponectin productionQ42829765
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue6
P304page(s)415-422
P577publication date2013-12-01
P1433published inDiabetes & metabolism journalQ26842420
P1476titleDiabetogenic effect of statins: a double-edged sword?
P478volume37

Reverse relations

cites work (P2860)
Q36835349Association of statin use and stress-induced hyperglycemia in patients with acute ST-elevation myocardial infarction
Q26783435Effects of Vaccinium Berries on Serum Lipids: A Meta-Analysis of Randomized Controlled Trials
Q55313005Phenotyping of Korean patients with better-than-expected efficacy of moderate-intensity statins using tensor factorization.
Q38890066Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea
Q38599323Statins and their increased risk of inducing diabetes
Q38976878Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans

Search more.